HALO logo
halo search icon
Syntara Limited
Syntara Limited
SNT · ASX

Syntara Limited

AU$0.026

0.00 (0.00%)
19/05/2026 02:43:34 PM
All-CompaniesAll-ConsensusGROWTH AUSHALO Consensus ValueHALO OrdsHALO Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Syntara Limited Overview

SNT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About SNT

icon

Telephone

61.2.8760.1480

icon

Address

Unit 2, Frenchs Forest, 20 Rodborough Road, Sydney, New South Wales (NSW) 2086

Description

Syntara Ltd. is a clinical stage drug development company which engages in the development of healthcare products for haematological diseases. Its lead compounds include amsulostat (SNT-5055) and topical pan-LOX inhibitors with SNT-9495. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.

SNT Price Chart

Key Stats

Market Cap

AU$48.80M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.08

Trade Value (12mth)

AU$51,855.00

1 week

-3.7%

1 month

-23.53%

YTD

-23.53%

1 year

-63.38%

All time high

4.31

Key Fundamentals

EPS 3 yr Growth

58.80%

EBITDA Margin

0.00%

Operating Cashflow

-$11m

Free Cash Flow Return

-107.00%

ROIC

-118.00%

Interest Coverage

-648.30

Quick Ratio

3.90

Other Data

Shares Outstanding (Fully Diluted)

1,628m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.03

SNT Announcements

Latest Announcements

DateAnnouncements
19 May 26
14 May 26
14 May 26
12 May 26
11 May 26

SNT Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.02-0.02-0.01locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.02-0.02-0.01locklocklock
Growth
%locklocklocklock-408.8-26.675.3locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

0.03%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

-0.10%

3 Months Change

-0.10%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

SNT Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Syntara Limited (SNT:ASX)?
Halo FAQ
The current share price of Syntara Limited (SNT:ASX) is AUD$0.03.
What is the 52-week high share price for Syntara Limited (SNT:ASX)?
Halo FAQ
The 52-week high share price for Syntara Limited (SNT:ASX) is AUD$0.08.
What is the 52-week low share price for Syntara Limited (SNT:ASX)?
Halo FAQ
The 52-week low share price for Syntara Limited (SNT:ASX) is AUD$0.02.
What is the dividend yield for Syntara Limited (SNT:ASX)?
Halo FAQ
Syntara Limited (SNT:ASX) does not pay a dividend.
What was Syntara Limited (SNT:ASX) last dividend payment?
Halo FAQ
Syntara Limited (SNT:ASX) does not pay a dividend.
What is the franking level for Syntara Limited (SNT:ASX)?
Halo FAQ
Syntara Limited (SNT:ASX) has a franking level of 0.00%.
In which sector is Syntara Limited (SNT:ASX) classified?
Halo FAQ
Syntara Limited (SNT:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.